The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Artemisinin API Market Research Report 2025
Synopsis
Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.
The global Artemisinin API market was valued at US$ 763 million in 2023 and is anticipated to reach US$ 1256.8 million by 2030, witnessing a CAGR of 8.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Artemisinin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artemisinin API.
Report Scope
The Artemisinin API market size, estimations, and forecasts are provided in terms of output/shipments (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artemisinin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artemisinin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
KPC Pharmaceuticals
Kerui nanhai
Guangxi xiancaotang
Guilin Pharmaceutical
Natural Bio-engineering
BIONEXX
CAT KHANH
BEEPZ
Novanat Bioresource
Segment by Type
Extraction from Artemisia annua
Semisynthetic Artemisinin
Segment by Application
Antimalarial Injections
Antimalarial Tablets
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artemisinin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Artemisinin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Artemisinin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Artemisinin is a sesquiterpene lactone containing an unusual peroxide bridge which possesses the most rapid action of all current drugs against Plasmodium falciparum malaria. It is isolated from the plant Artemisia annua, sweet wormwood, an herb employed in Chinese traditional medicine. It can now also be produced using genetically engineered yeast.
The global Artemisinin API market was valued at US$ 763 million in 2023 and is anticipated to reach US$ 1256.8 million by 2030, witnessing a CAGR of 8.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Artemisinin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artemisinin API.
Report Scope
The Artemisinin API market size, estimations, and forecasts are provided in terms of output/shipments (Kiloton) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artemisinin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artemisinin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
KPC Pharmaceuticals
Kerui nanhai
Guangxi xiancaotang
Guilin Pharmaceutical
Natural Bio-engineering
BIONEXX
CAT KHANH
BEEPZ
Novanat Bioresource
Segment by Type
Extraction from Artemisia annua
Semisynthetic Artemisinin
Segment by Application
Antimalarial Injections
Antimalarial Tablets
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artemisinin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Artemisinin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Artemisinin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Artemisinin API Market Overview
1.1 Product Definition
1.2 Artemisinin API Segment by Type
1.2.1 Global Artemisinin API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Extraction from Artemisia annua
1.2.3 Semisynthetic Artemisinin
1.3 Artemisinin API Segment by Application
1.3.1 Global Artemisinin API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Antimalarial Injections
1.3.3 Antimalarial Tablets
1.4 Global Market Growth Prospects
1.4.1 Global Artemisinin API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Artemisinin API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Artemisinin API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Artemisinin API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Artemisinin API Production Market Share by Manufacturers (2019-2024)
2.2 Global Artemisinin API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Artemisinin API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Artemisinin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Artemisinin API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Artemisinin API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Artemisinin API, Product Offered and Application
2.8 Global Key Manufacturers of Artemisinin API, Date of Enter into This Industry
2.9 Artemisinin API Market Competitive Situation and Trends
2.9.1 Artemisinin API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Artemisinin API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Artemisinin API Production by Region
3.1 Global Artemisinin API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Artemisinin API Production Value by Region (2019-2030)
3.2.1 Global Artemisinin API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Artemisinin API by Region (2025-2030)
3.3 Global Artemisinin API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Artemisinin API Production by Region (2019-2030)
3.4.1 Global Artemisinin API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Artemisinin API by Region (2025-2030)
3.5 Global Artemisinin API Market Price Analysis by Region (2019-2024)
3.6 Global Artemisinin API Production and Value, Year-over-Year Growth
3.6.1 North America Artemisinin API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Artemisinin API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Artemisinin API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Artemisinin API Production Value Estimates and Forecasts (2019-2030)
4 Artemisinin API Consumption by Region
4.1 Global Artemisinin API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Artemisinin API Consumption by Region (2019-2030)
4.2.1 Global Artemisinin API Consumption by Region (2019-2024)
4.2.2 Global Artemisinin API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Artemisinin API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Artemisinin API Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Artemisinin API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Artemisinin API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Artemisinin API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Artemisinin API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Artemisinin API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Artemisinin API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Artemisinin API Production by Type (2019-2030)
5.1.1 Global Artemisinin API Production by Type (2019-2024)
5.1.2 Global Artemisinin API Production by Type (2025-2030)
5.1.3 Global Artemisinin API Production Market Share by Type (2019-2030)
5.2 Global Artemisinin API Production Value by Type (2019-2030)
5.2.1 Global Artemisinin API Production Value by Type (2019-2024)
5.2.2 Global Artemisinin API Production Value by Type (2025-2030)
5.2.3 Global Artemisinin API Production Value Market Share by Type (2019-2030)
5.3 Global Artemisinin API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Artemisinin API Production by Application (2019-2030)
6.1.1 Global Artemisinin API Production by Application (2019-2024)
6.1.2 Global Artemisinin API Production by Application (2025-2030)
6.1.3 Global Artemisinin API Production Market Share by Application (2019-2030)
6.2 Global Artemisinin API Production Value by Application (2019-2030)
6.2.1 Global Artemisinin API Production Value by Application (2019-2024)
6.2.2 Global Artemisinin API Production Value by Application (2025-2030)
6.2.3 Global Artemisinin API Production Value Market Share by Application (2019-2030)
6.3 Global Artemisinin API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Sanofi
7.1.1 Sanofi Artemisinin API Corporation Information
7.1.2 Sanofi Artemisinin API Product Portfolio
7.1.3 Sanofi Artemisinin API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Sanofi Main Business and Markets Served
7.1.5 Sanofi Recent Developments/Updates
7.2 KPC Pharmaceuticals
7.2.1 KPC Pharmaceuticals Artemisinin API Corporation Information
7.2.2 KPC Pharmaceuticals Artemisinin API Product Portfolio
7.2.3 KPC Pharmaceuticals Artemisinin API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 KPC Pharmaceuticals Main Business and Markets Served
7.2.5 KPC Pharmaceuticals Recent Developments/Updates
7.3 Kerui nanhai
7.3.1 Kerui nanhai Artemisinin API Corporation Information
7.3.2 Kerui nanhai Artemisinin API Product Portfolio
7.3.3 Kerui nanhai Artemisinin API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Kerui nanhai Main Business and Markets Served
7.3.5 Kerui nanhai Recent Developments/Updates
7.4 Guangxi xiancaotang
7.4.1 Guangxi xiancaotang Artemisinin API Corporation Information
7.4.2 Guangxi xiancaotang Artemisinin API Product Portfolio
7.4.3 Guangxi xiancaotang Artemisinin API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Guangxi xiancaotang Main Business and Markets Served
7.4.5 Guangxi xiancaotang Recent Developments/Updates
7.5 Guilin Pharmaceutical
7.5.1 Guilin Pharmaceutical Artemisinin API Corporation Information
7.5.2 Guilin Pharmaceutical Artemisinin API Product Portfolio
7.5.3 Guilin Pharmaceutical Artemisinin API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Guilin Pharmaceutical Main Business and Markets Served
7.5.5 Guilin Pharmaceutical Recent Developments/Updates
7.6 Natural Bio-engineering
7.6.1 Natural Bio-engineering Artemisinin API Corporation Information
7.6.2 Natural Bio-engineering Artemisinin API Product Portfolio
7.6.3 Natural Bio-engineering Artemisinin API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Natural Bio-engineering Main Business and Markets Served
7.6.5 Natural Bio-engineering Recent Developments/Updates
7.7 BIONEXX
7.7.1 BIONEXX Artemisinin API Corporation Information
7.7.2 BIONEXX Artemisinin API Product Portfolio
7.7.3 BIONEXX Artemisinin API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 BIONEXX Main Business and Markets Served
7.7.5 BIONEXX Recent Developments/Updates
7.8 CAT KHANH
7.8.1 CAT KHANH Artemisinin API Corporation Information
7.8.2 CAT KHANH Artemisinin API Product Portfolio
7.8.3 CAT KHANH Artemisinin API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 CAT KHANH Main Business and Markets Served
7.7.5 CAT KHANH Recent Developments/Updates
7.9 BEEPZ
7.9.1 BEEPZ Artemisinin API Corporation Information
7.9.2 BEEPZ Artemisinin API Product Portfolio
7.9.3 BEEPZ Artemisinin API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 BEEPZ Main Business and Markets Served
7.9.5 BEEPZ Recent Developments/Updates
7.10 Novanat Bioresource
7.10.1 Novanat Bioresource Artemisinin API Corporation Information
7.10.2 Novanat Bioresource Artemisinin API Product Portfolio
7.10.3 Novanat Bioresource Artemisinin API Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Novanat Bioresource Main Business and Markets Served
7.10.5 Novanat Bioresource Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Artemisinin API Industry Chain Analysis
8.2 Artemisinin API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Artemisinin API Production Mode & Process
8.4 Artemisinin API Sales and Marketing
8.4.1 Artemisinin API Sales Channels
8.4.2 Artemisinin API Distributors
8.5 Artemisinin API Customers
9 Artemisinin API Market Dynamics
9.1 Artemisinin API Industry Trends
9.2 Artemisinin API Market Drivers
9.3 Artemisinin API Market Challenges
9.4 Artemisinin API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
